A Swiss newspaper reported that the U.S. is considering placing tariffs on exports of pharmaceutical goods from Switzerland, according to Endpoints News.
The Trump administration reportedly is bothered by the $18.9 billion trade deficit with Switzerland, which is mainly driven by pharmaceuticals.
While the tariffs do not appear to be an immediate threat, they could potentially affect Swiss pharma giants Novartis and Roche and other manufacturers that produce drugs in Switzerland, like Merck and Biogen.
Read the full report here.